Wegovy 0.5mg is a prescription-based medication for weight management. It is primarily indicated for adults and adolescents who are overweight or obese or who have a weight-related medical condition. Novo Nordisk India Ltd manufactures the product.
It contains an FDA-approved active ingredient: Semaglutide, a GLP-1 (Glucagon-Like Peptide-1) receptor agonist. It mimics the natural GLP-1 hormone, which helps regulate appetite and calorie consumption, thereby supporting weight loss. It also reduces the chance of cardiovascular issues like stroke or heart attack in these individuals.
Some common side effects are nausea, vomiting, and diarrhea. When used with medications like Insulin, Sulfonylureas, or Meglitinides, there is a risk of Hypoglycemia (low blood sugar). Alcohol can intensify these side effects, which users should avoid. Users with a history of thyroid cancer or Pancreatitis should avoid using Wegovy due to its potential health risks.
Always inform your doctor about all your medications and underlying health conditions to prevent complications. The dosage and duration should always be under medical supervision. Discontinue only when a doctor or healthcare professional gives consent.
Wegovy 0.5mg/0.5ml of pen injection offers several benefits for overweight or obese individuals:
Wegovy 0.5 mg injection is a prescription-based medication that patients should take according to their doctor's instructions. Here are some general guidelines for this medication.
The strengths and substitutes available for Wegovy 0.5mg at Cheap Medicine Shop are:
| Wegovy 1.7mg | $378.58/injection |
| Wegovy 2.4mg | $405.83/injection |
The side effects of Wegovy 0.5mg include:
They are generally mild and will disappear as the body adjusts to the medication. However, if they continue or worsen, consult a doctor immediately.
Liver disease
The medication is typically safe for patients with mild to moderate liver disease. However, medical supervision should be taken as a precaution. Dose adjustments might be required for patients with severe liver disease.
Kidney impairment
Patients with kidney impairment should use the medication with caution, as gastrointestinal side effects may lead to dehydration. Consult a doctor for possible dose adjustments and close monitoring of kidney function.
Pregnancy and breastfeeding
Wegovy 0.5mg should be avoided during pregnancy as the weight-loss effect can be harmful to the fetus. Nursing mothers should consult with their healthcare provider before using any medication.
Avoid
Avoid taking the medication if you are allergic to Semaglutide. Alcohol intake can increase the chance of side effects, which patients should avoid.
No, Wegovy should not be stopped abruptly without a doctor's guidance, as it may cause side effects and rapid weight regain. Always consult with your healthcare provider to decide how long to continue the medication or if you're considering stopping it.
No, you should not start Wegovy directly at 0.5 mg. The usual treatment begins with 0.25 mg once weekly for four weeks and gradually increases to 0.5 mg weekly to reduce side effects. Always follow your healthcare provider's dosing plan for safe, effective use.
Wegovy 0.5mg injection is generally safe for long-term usage when prescribed and monitored by a doctor. While it can cause mild to serious side effects, ongoing monitoring helps manage risks. Clinical studies support its safety when used as directed for chronic weight management.
Wegovy is approved and generally safe for adolescents aged 12 to 17 with obesity or overweight plus weight-related health issues, under medical supervision. There is no established data on its safety and effectiveness for children under 12, so use in that group is not recommended.
Wegovy 0.5mg injection pens should be refrigerated at 2°C to 8°C (36°F to 46°F) in their original carton. They can be kept at room temperature (8°C to 30°C or 46°F to 86°F) for up to 28 days, but must not be frozen. After first use, store below 30°C or refrigerate and use within 6 to 8 weeks. Protect from light and remove the needle after each use.
You will start seeing results after the first four weeks of taking Wegovy, often around 2% reduction in body weight if combined with an improved diet and regular exercise. However, visible changes may vary from individual to individual.
No, the typical starting dosage of Wegovy is 0.25 mg per week. This allows your body to get used to it, lowering the risk of side effects. Then, you gradually increase to 0.5 mg strength. Consult a doctor before switching to a different strength.